Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Phathom Pharmaceuticals Inc (PHAT)

Phathom Pharmaceuticals Inc (PHAT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.41 +0.19 (+4.50%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.45 +0.04 (+0.91%) 18:25 ET
Income Statement for Fri, Mar 14th, 2025
Try Excel Barchart for Excel
Watch
    Add or delete the symbol from one or more Watchlists.

Fiscal Year End Date: 12/31

(Values in U.S. thousands)
  12-2024 12-2023 12-2022 12-2021 12-2020
Sales 55,252 682 0 0 0
Cost of Goods 7,973 167 N/A N/A N/A
Gross Profit 47,279 515 N/A N/A N/A
Operating Expenses 325,719 167,994 172,440 135,080 125,665
Operating Income -277,467 -167,312 -172,440 -135,080 -125,665
Interest Expense 72,009 41,968 27,305 6,788 4,581
Other Income 15,150 7,688 2,022 -2,015 1,178
Pre-tax Income -334,326 -201,592 -197,723 -143,883 -129,068
Net Income Continuous -334,326 -201,592 -197,723 -143,883 -129,068
Net Income $-334,326 $-201,592 $-197,723 $-143,883 $-129,068
EPS Basic Total Ops -5.29 -3.93 -5.05 -3.89 -3.88
EPS Basic Continuous Ops -5.29 -3.93 -5.05 -3.89 -3.88
EPS Diluted Total Ops -5.29 -3.93 -5.05 -3.89 -3.88
EPS Diluted Continuous Ops -5.29 -3.93 -5.05 -3.89 -3.88
EPS Diluted Before Non-Recurring Items N/A -2.53 -5.05 -3.89 -3.88
EBITDA(a) $-274,480 $-164,860 $-169,710 $-130,964 $-124,069
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals